Medigene AG (FRA:MDG1)
Germany · Delayed Price · Currency is EUR 0.0436
+0.0006 (1.40%)
Jan 30, 2026, 12:10 PM CET
Medigene AG Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -15.93 | -16.18 | -8.33 | -9.98 | -28.88 | -19.96 |
Depreciation & Amortization | 1.5 | 1.46 | 21.85 | 3.43 | 4.26 | 2.37 |
Loss (Gain) From Sale of Assets | - | - | 0.03 | 0.16 | 0.03 | - |
Asset Writedown & Restructuring Costs | - | - | - | - | 2.21 | - |
Loss (Gain) From Sale of Investments | - | - | - | -0.06 | -0.58 | -0.6 |
Stock-Based Compensation | 0.27 | 0.31 | 0.35 | 0.65 | 0.66 | 0.49 |
Other Operating Activities | 0.64 | -0.42 | -1.04 | -0.26 | 0.36 | -0.18 |
Change in Accounts Receivable | 2.83 | 2.57 | -2.28 | 0.91 | 2.65 | 0.34 |
Change in Inventory | - | - | - | - | - | 0.31 |
Change in Accounts Payable | -2.98 | -0.29 | 0.14 | 0.07 | -0.94 | 0.02 |
Change in Other Net Operating Assets | -0.5 | -2.57 | 1.26 | -5.66 | -4.57 | 0.8 |
Operating Cash Flow | -14.17 | -15.12 | 11.98 | -10.75 | -24.79 | -16.42 |
Capital Expenditures | -0.62 | -0.66 | -0.96 | -0.13 | -0.48 | -1.43 |
Sale of Property, Plant & Equipment | 0.05 | 0.05 | 0 | 0.03 | 0.02 | - |
Sale (Purchase) of Intangibles | 0.1 | - | -0.05 | - | 1 | 1 |
Investment in Securities | 8 | 3 | -11 | 4.12 | 20.58 | 24.59 |
Other Investing Activities | - | - | - | - | 0 | - |
Investing Cash Flow | 7.53 | 2.38 | -12.01 | 4.03 | 21.12 | 24.17 |
Short-Term Debt Issued | - | - | - | - | - | 0.96 |
Total Debt Issued | - | - | - | - | - | 0.96 |
Short-Term Debt Repaid | - | - | - | - | - | -0.2 |
Long-Term Debt Repaid | - | -0.78 | -0.28 | -1.03 | -0.83 | -1.25 |
Total Debt Repaid | -1.78 | -0.78 | -0.28 | -1.03 | -0.83 | -1.45 |
Net Debt Issued (Repaid) | -1.78 | -0.78 | -0.28 | -1.03 | -0.83 | -0.49 |
Issuance of Common Stock | - | - | - | - | - | 0.02 |
Other Financing Activities | 5.9 | - | - | - | - | - |
Financing Cash Flow | 4.11 | -0.78 | -0.28 | -1.03 | -0.83 | -0.47 |
Foreign Exchange Rate Adjustments | 0.01 | -0.04 | 0.12 | 0.14 | -0.16 | - |
Miscellaneous Cash Flow Adjustments | - | - | - | 0 | - | - |
Net Cash Flow | -2.53 | -13.55 | -0.19 | -7.62 | -4.65 | 7.27 |
Free Cash Flow | -14.79 | -15.78 | 11.02 | -10.88 | -25.27 | -17.85 |
Free Cash Flow Margin | -198.68% | -261.57% | 35.27% | -103.98% | -315.80% | -169.83% |
Free Cash Flow Per Share | -1.17 | -1.28 | 0.90 | -0.89 | -2.06 | -1.45 |
Cash Interest Paid | 0.25 | 0.25 | 0.31 | 0.33 | 0.4 | 0.41 |
Cash Income Tax Paid | - | - | - | - | 0.1 | 0.1 |
Levered Free Cash Flow | -6.25 | -6.93 | 25.12 | -2.37 | -11.61 | -6.36 |
Unlevered Free Cash Flow | -5.91 | -6.59 | 25.52 | -2.15 | -11.36 | -6.08 |
Change in Working Capital | -0.65 | -0.3 | -0.89 | -4.68 | -2.86 | 1.46 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.